Return to Arthritis & Rheumatism Table of Contents Page
| Special Articles |
|
|---|---|
| 2085 |
Editorial: Tuberculosis in the Cytokine Era: What Rheumatologists Need to Know |
| Carol Dukes Hamilton |
|
2092 |
Editorial: The JAK/STAT Pathway in Rheumatoid Arthritis: Pathogenic or Protective? |
|
|
Lionel B. Ivashkiv and Xiaoyu Hu |
| 2097 |
Editorial: What Is ``Resistance'' in Paget's Disease of Bone? |
| Kenneth W. Lyles |
|
| 2100 |
Review: Sex Hormones and Systemic Lupus Erythematosus: Review and Meta-Analysis |
|
|
Robert W. McMurray and Warren May |
| 2111 |
Review: How Do Antiphospholipid Antibodies Bind [beta]2-Glycoprotein I? |
| Ian P. Giles, David A. Isenberg, David S. Latchman, and Anisur Rahman |
|
Rheumatoid Arthritis |
|
| 2122 |
Treatment of Rheumatoid Arthritis With Tumor Necrosis Factor Inhibitors May Predispose to Significant Increase in Tuberculosis Risk: A Multicenter Active-Surveillance Report |
| Juan J. Gomez-Reino, Loreto Carmona, Vicente Rodriguez Valverde, Emilio Martin Mola, and Maria Dolores Montero, on behalf of the BIOBADASER Group |
|
| 2128 |
New Radiographic Bone Erosions in the Wrists of Patients With Rheumatoid Arthritis Are Detectable With Magnetic Resonance Imaging a Median of Two Years Earlier |
| Mikkel Ostergaard, Michael Hansen, Michael Stoltenberg, Karl Erik Jensen, Marcin Szkudlarek, Brigitta Pedersen-Zbinden, and Ib Lorenzen |
|
| 2132 |
Rheumatoid Arthritis Is a Heterogeneous Disease: Evidence for Differences in the Activation of the STAT-1 Pathway Between Rheumatoid Tissues |
| Tineke C. T. M. van der Pouw Kraan, Floris A. van Gaalen, Pia V. Kasperkovitz, Nicolette L. Verbeet, Tom J. M. Smeets, Maarten C. Kraan, Mike Fero, Paul-Peter Tak, Tom W. J. Huizinga, Elsbet Pieterman, Ferdinand C. Breedveld, Ash A. Alizadeh, and Cornelis L. Verweij |
|
| 2146 |
Serologic Changes Following B Lymphocyte Depletion Therapy for Rheumatoid Arthritis |
| Geraldine Cambridge, Maria J. Leandro, Jonathan C. W. Edwards, Michael R. Ehrenstein, Martin Salden, Mark Bodman-Smith, and Anthony D. B. Webster |
|
| 2155 |
Tumor Necrosis Factor [alpha] Blockade Reduces the Synovial Cell Infiltrate Early After Initiation of Treatment, but Apparently Not by Induction of Apoptosis in Synovial Tissue |
| Tom J. M. Smeets, Maarten C. Kraan, Marieke E. van Loon, and Paul-Peter Tak |
|
| 2163 |
Synovial Fluid Exoglycosidases Are Predictors of Rheumatoid Arthritis and Are Effective in Cartilage Glycosaminoglycan Depletion |
| Zsuzsanna Ortutay, Anna Polgar, Bela Gomor, Pal Geher, Tamas Lakatos, Tibor T. Glant, Renate E. Gay, Steffen Gay, Eva Pallinger, Csaba Farkas, Eva Farkas, Laszlo Tothfalusi, Katalin Kocsis, Anras Falus, and Edit I. Buzas |
|
Osteoarthritis and Cartilage |
|
| 2173 |
Inflammation and Angiogenesis in Osteoarthritis |
| L. Haywood, D. F. McWilliams, C. I. Pearson, S. E. Gill, A. Ganesan, D. Wilson, and D. A. Walsh |
|
| 2178 |
Impact of Type of Meniscal Tear on Radiographic and Symptomatic Knee Osteoarthritis: A Sixteen-Year Followup of Meniscectomy With Matched Controls |
| M. Englund, E. M. Roos, and L. S. Lohmander |
|
| 2188 |
The Combination of Insulin-Like Growth Factor 1 and Osteogenic Protein 1 Promotes Increased Survival of and Matrix Synthesis by Normal and Osteoarthritic Human Articular Chondrocytes |
| Richard F. Loeser, Carol A. Pacione, and Susan Chubinskaya |
|
| 2197 |
High Binding Capacity of Cyclophilin B to Chondrocyte Heparin Sulfate Proteoglycans and Its Release From the Cell Surface by Matrix Metalloproteinases: Possible Role as a Proinflammatory Mediator in Arthritis Treatment |
| Frederic De Ceuninick, Fabrice Allain, Audrey Caliez, Genevieve Spik, and Paul M. Vanhoutte |
|
| 2207 |
Arthritis Self-Management Education Programs: A Meta-Analysis of the Effect on Pain and Disability |
| Asra Warsi, Michael P. LaValley, Philip S. Wang, Jerry Avorn, and Daniel H. Solomon |
|
Childhood Arthritis |
|
| 2214 |
Frequency of Osteopenia in Adolescents With Early-Onset Juvenile Idiopathic Arthritis: A Long-Term Outcome Study of One Hundred Five Patients |
| Gunhild Lien, Berit Flat\o, Margaretha Haugen, Odd Vinje, Dag S\orskaar, Knut Dale, Virginia Johnston, Thore Egeland, and Oystein F\orre |
|
Spondylarthropathy |
|
| 2224 |
Long-Term Efficacy and Safety of Infliximab in the Treatment of Ankylosing Spondylitis: An Open, Observational, Extension Study of a Three-Month, Randomized, Placebo-Controlled Trial |
| J. Braun, J. Brandt, J. Listing, A. Zink, R. Alten, G. Burmester, W. Golder, E. Gromnica-Ihle, H. Kellner, M. Schneider, H. Sorensen, H. Zeidler, J. Reddig, and J. Sieper |
|
| 2234 |
Identification of Major Loci Controlling Clinical Manifestations of Ankylosing Spondylitis |
| Matthew A. Brown, Sinead Brophy, Linda Bradbury, Jasmin Hamersma, Andrew Timms, Steven Laval, Lon Cardon, Andrei Calin, and B. Paul Wordsworth |
|
Sjogren's Syndrome |
|
| 2240 |
In Primary Sjogren's Syndrome, HLA Class II Is Associated Exclusively With Autoantibody Production and Spreading of the Autoimmune Response |
| Jacques-Eric Gottenberg, Marc Busson, Pascale Loiseau, Julien Cohen-Solal, Virginia Lepage, Dominique Charron, Jean Sibilia, and Xavier Mariette |
|
Systemic Sclerosis |
|
| 2246 |
Prevalence, Incidence, Survival, and Disease Characteristics of Systemic Sclerosis in a Large US Population |
| Maureen D. Mayes, James V. Lacey, Jr., Jennifer Beebe-Dimmer, Brenda W. Gillespie, Brenda Cooper, Timothy J. Laing, and David Schottenfeld |
|
| 2256 |
Effects of Oral Cyclophosphamide and Prednisolone Therapy on the Endothelial Functions and Clinical Findings in Patients With Early Diffuse Systemic Sclerosis |
| Sule Apras, Ihsan Ertenli, Zeynep Ozbalkan, Sedat Kiraz, M. Akif Ozturk, Ibrahim C. Haznedaroglu, Veli Cobankara, Salih Pay, and Meral Calguneri |
|
| 2262 |
Occurrence of an Activated, Profibrotic Pattern of Gene Expression in Lung CD8+ T Cells From Scleroderma Patients |
| Irina G. Luzina, Sergei P. Atamas, Robert Wise, Fredrick M. Wigley, Jung Choi, Hui Qing Xiao, and Barbara White |
|
| 2275 |
Molecular Mechanisms of Interleukin-4-Induced Up-Regulation of Type I Collagen Gene Expression in Murine Fibroblasts |
| Tracy L. McGaha, Maithao Le, Takao Kodera, Cristina Stoica, Jinfang Zhu, William E. Paul, and Constantin A. Bona |
|
Muscle Disease |
|
| 2285 |
Global Surface Ultraviolet Radiation Intensity May Modulate the Clinical and Immunologic Expression of Autoimmune Muscle Disease |
| Satoshi Okada, Elizabeth Weatherhead, Ira N. Targoff, Robert Wesley, and Frederick W. Miller, for the International Myositis Collaborative Study Group |
|
| 2294 |
Bone Mineral Density in Juvenile Dermatomyositis: Assessment Using Dual X-Ray Absorptiometry |
| W. A. Stewart, P. D. Acott, S. R. Salisbury, and B. A. Lang |
|
Vasculitis |
|
| 2299 |
Limited Versus Severe Wegener's Granulomatosis: Baseline Data on Patients in the Wegener's Granulomatosis Etanercept Trial |
|
|
The Wegener's Granulomatosis Etanercept Trial Research Group |
Gout |
|
2310 |
Role of S100A8 and S100A9 in Neutrophil Recruitment in Response to Monosodium Urate Monohydrate Crystals in the Air-Pouch Model of Acute Gouty Arthritis |
|
|
Carle Ryckman, Shaun R. McColl, Karen Vandal, Rinaldo de Medicis, Andre Lussier, Patrice E. Poubelle, and Philippe A. Tessier |
| Paget's Disease |
|
| 2321 |
Bisphosphonate Resistance in Paget's Disease of Bone |
| Fred Joshua, Martin Epstein, and Gabor Major |
|
|
|
|
Familial Mediterranean Fever |
|
| 2324 |
Familial Mediterranean Fever Among Patients From Karabakh and the Diagnostic Value of MEFV Gene Analysis in All Classically Affected Populations |
| Cecile Cazeneuve, Zaruhi Hovannesyan, David Genevieve, Hasmik Hayrapetyan, Stephanie Papin, Emmanuelle Girodon-Boulandet, Brigitte Boissier, Josue Feingold, Karine Atayan, Tamara Sarkisian, and Serge Amselem |
|
|
|
|
Immune Mechanisms |
|
| 2332 |
A Comparative Genetic Analysis Between Collagen-Induced Arthritis and Pristane-Induced Arthritis |
| Peter Olofsson, Shemin Lu, Jens Holmberg, Tusheng Song, Patrik Wernhoff, Ulf Pettersson, and Rikard Holmdahl |
|
| 2343 |
Use of a Novel Elution Regimen Reveals the Dominance of Polyreactive Antinuclear Autoantibodies in Lupus Kidneys |
| Chun Xie, Zhiyan Liang, Sooghee Chang, and Chandra Mohan |
|
| 2353 |
Defects in the Regulation of B Cell Apoptosis Are Required for the Production of Citrullinated Peptide Autoantibodies in Mice |
| Marcos Lopez-Hoyos, Regina Marquina, Esther Tamayo, Jovanna Gonzalez-Rojas, Shozo Izui, Ramon Marino, and Jesus Merino |
|
| 2362 |
Dendritic Cell Uptake of Human Apoptotic and Necrotic Neutrophils Inhibits CD40, CD80, and CD86 Expression and Reduces Allogeneic T Cell Responses: Relevance to Systemic Vasculitis |
| Abigail R. Clayton, Rebecca L. Prue, Lorraine Harper, Mark T. Drayson, and Caroline O. S. Savage |
|
| 2375 |
Cytokines Elicited by T Cell Epitopes From a Synovial Autoantigen: Altered Peptide Ligands Can Reduce Interferon-[gamma] and Interleukin-10 Production |
| Frances C. Hall, Kevin C. Visconti, Regina-Celeste Ahmad, Sarah L. Parry, Andre M. M. Miltenburg, Harden M. McConnell, Elizabeth D. Mellins, and Grete S\onderstrup |
|
Concise Communication |
|
| 2386 |
Tumor Necrosis Factor Receptor-Associated Periodic Syndrome Characterized by a Mutation Affecting the Cleavage Site of the Receptor: Implications for Pathogenesis |
| Martin A. Kriegel, Ulrike Huffmeier, Elisabeth Scherb, Christina Scheidig, Thomas Geiler, Joachim R. Kalden, Andre Reis, and Hanns-Martin Lorenz |
|
Letters |
|
| 2389 |
Availability of Drugs Should Be Disclosed by Manufacturers |
| Bruce Rothschild |
|
| 2389 |
Lymphomas After Tumor Necrosis Factor Antagonist Therapy: Comment on the Article by Brown et al |
| Hasan Yazici |
|
| 2390 |
Expression of the Interferon-[gamma]-Inducible 10-kd Protein and CXC Receptor 3 in the Salivary Gland Lesions of Patients With Sjogren's Syndrome: Comment on the Article by Ogawa et al |
| P. Sfriso, F. Calabrese, C. Grava, C. Agostini, L. Punzi, F. Oliviero, C. Botsios, P. A. Ostuni, and S. Todesco |
|
| 2391 |
Reply |
| Noriyoshi Ogawa, Li Ping, and Susumu Sugai |
|
| ACR Announcements |
|
| XXA |
|
| Cover image: The figure on the cover (from Loeser et al, page 2192) illustrates an assay for cell-associated matrix of chondrocytes that had been cultured in alginate beads in the presence of insulin-like growth factor 1 and osteogenic protein 1. After dissolution of the beads, cells are incubated with fixed erythrocytes. The matrix excludes the erythrocytes, providing a convenient assay to assess factors promoting matrix production. |
|




